S&P 500 7,757.17 +0.58%
Nasdaq 26,702.86 +1.05%
S&P/TSX 36,324.99 +0.60%
Apple 343.99 +1.32%
Nvidia 221.97 +2.54%
Microsoft 532.95 +0.20%
Shopify 244.93 +0.38%
Royal Bank 283.62 +1.23%
CAD/USD 0.7129 +0.28%
CLOSED · 02:35 ET
Market ClerkRecap
Thu Oct 22 · markets closed2 signals on Oct 21108 insider buys this week · $250.3MCIRO short report next: Oct 30The week ahead
CJ
INSIDER · MAZE · Maze Therapeutics, Inc. · CHIEF EXECUTIVE OFFICER

Coloma Jason V

Every open-market transaction filed under this name, Sep 1 to Oct 1.

Filings
8
0 buys · 8 sells
Bought
—
open market, at cost
Sold
$2.4M
includes scheduled sales
Buys since
—
no current price on file

Filings

SEC FORM 4 · OPEN MARKET
TradedTickerCompanyRoleTypeSharesPriceValueSince
Oct 1MAZEMaze Therapeutics, Inc.Chief Executive OfficerSell31,908$27.02$862K—
Oct 1MAZEMaze Therapeutics, Inc.Chief Executive OfficerSell2,593$27.02$70K—
Sep 3MAZEMaze Therapeutics, Inc.Chief Executive OfficerSell129$25.77$3K—
Sep 3MAZEMaze Therapeutics, Inc.Chief Executive OfficerSell11,282$26.01$293K—
Sep 2MAZEMaze Therapeutics, Inc.Chief Executive OfficerSell1,375$27.12$37K—
Sep 2MAZEMaze Therapeutics, Inc.Chief Executive OfficerSell9,852$26.38$260K—
Sep 1MAZEMaze Therapeutics, Inc.Chief Executive OfficerSell31,908$26.29$839K—
Sep 1MAZEMaze Therapeutics, Inc.Chief Executive OfficerSell2,593$26.31$68K—

"Since" is the stock's move from the filed price to the latest quote on file, not a scored call. Open-market purchases and sales only; option exercises and grants are excluded.